Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis LD Jacobs, RW Beck, JH Simon, RP Kinkel, CM Brownscheidle, ... New England Journal of Medicine 343 (13), 898-904, 2000 | 2011 | 2000 |
Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change RHB Benedict, E Wahlig, R Bakshi, I Fishman, F Munschauer, ... Journal of the Neurological Sciences 231 (1), 29-34, 2005 | 798 | 2005 |
Quality of life in patients with multiple sclerosis: the impact of fatigue and depression V Janardhan, R Bakshi Journal of the Neurological Sciences 205 (1), 51-58, 2002 | 707 | 2002 |
Fatigue in multiple sclerosis and its relationship to depression and neurologic disability R Bakshi, ZA Shaikh, RS Miletich, D Czarnecki, J Dmochowski, ... Multiple Sclerosis Journal 6 (3), 181-185, 2000 | 669 | 2000 |
Fatigue associated with multiple sclerosis: diagnosis, impact and management R Bakshi Multiple Sclerosis Journal 9 (3), 219-227, 2003 | 634 | 2003 |
Thalamic atrophy and cognition in multiple sclerosis MK Houtchens, RHB Benedict, R Killiany, J Sharma, Z Jaisani, B Singh, ... Neurology 69 (12), 1213-1223, 2007 | 617 | 2007 |
The measurement and clinical relevance of brain atrophy in multiple sclerosis RA Bermel, R Bakshi The Lancet Neurology 5 (2), 158-170, 2006 | 579 | 2006 |
Benefit of interferon β-1a on MSFC progression in secondary progressive MS JA Cohen, GR Cutter, JS Fischer, AD Goodman, FR Heidenreich, ... Neurology 59 (5), 679-687, 2002 | 510 | 2002 |
Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden RHB Benedict, B Weinstock-Guttman, I Fishman, J Sharma, CW Tjoa, ... Archives of Neurology 61 (2), 226-230, 2004 | 502 | 2004 |
Acute disseminated encephalomyelitis in children SNK Murthy, HS Faden, ME Cohen, R Bakshi Pediatrics 110 (2), e21-e21, 2002 | 462 | 2002 |
MRI in multiple sclerosis: current status and future prospects R Bakshi, AJ Thompson, MA Rocca, D Pelletier, V Dousset, F Barkhof, ... The Lancet Neurology 7 (7), 615-625, 2008 | 458 | 2008 |
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation L Mayo, SA Trauger, M Blain, M Nadeau, B Patel, JI Alvarez, ... Nature Medicine 20 (10), 1147-1156, 2014 | 436 | 2014 |
Gray matter involvement in multiple sclerosis I Pirko, CF Lucchinetti, S Sriram, R Bakshi Neurology 68 (9), 634-642, 2007 | 435 | 2007 |
Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis MP Sanfilipo, RHB Benedict, B Weinstock-Guttman, R Bakshi Neurology 66 (5), 685-692, 2006 | 401 | 2006 |
Validity of the beck depression inventory-fast screen in multiple sclerosis RHB Benedict, I Fishman, MM McClellan, R Bakshi, B Weinstock-Guttman Multiple Sclerosis 9 (4), 393-396, 2003 | 396 | 2003 |
Iron in chronic brain disorders: imaging and neurotherapeutic implications J Stankiewicz, SS Panter, M Neema, A Arora, CE Batt, R Bakshi Neurotherapeutics 4 (3), 371-386, 2007 | 364 | 2007 |
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. P Sati, J Oh, RT Constable, N Evangelou, CR Guttmann, RG Henry, ... Nature Reviews Neurology 12 (12), 714-722, 2016 | 352 | 2016 |
MRI findings in Susac’s syndrome JO Susac, FR Murtagh, RA Egan, JR Berger, R Bakshi, N Lincoff, ... Neurology 61 (12), 1783-1787, 2003 | 351 | 2003 |
IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event CHAMPIONS Study Group Neurology 66 (5), 678-684, 2006 | 344 | 2006 |
Smoking and disease progression in multiple sclerosis BC Healy, EN Ali, CRG Guttmann, T Chitnis, BI Glanz, G Buckle, ... Archives of Neurology 66 (7), 858-864, 2009 | 326 | 2009 |